205 related articles for article (PubMed ID: 8536358)
1. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
Ohtsuru I; Matsuo H; Fukudome T; Suenaga A; Tsujihata M; Nagataki S
Clin Exp Immunol; 1995 Dec; 102(3):462-7. PubMed ID: 8536358
[TBL] [Abstract][Full Text] [Related]
2. Total lymphoid irradiation and antigen-specific tolerance: future therapy for experimental myasthenia gravis?
de Silva S; McIntosh K; Blum JE; Order S; Mellits D; Drachman DB
J Neuroimmunol; 1990; 29(1-3):93-103. PubMed ID: 1698818
[TBL] [Abstract][Full Text] [Related]
3. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.
Fujii Y; Lindstrom J
J Immunol; 1988 Nov; 141(10):3361-9. PubMed ID: 2972772
[TBL] [Abstract][Full Text] [Related]
4. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
Fujii Y; Lindstrom J
J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
[TBL] [Abstract][Full Text] [Related]
5. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
Zoda T; Yeh TM; Krolick KA
J Immunol; 1991 Jan; 146(2):663-70. PubMed ID: 1987281
[TBL] [Abstract][Full Text] [Related]
6. Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis.
McIntosh KR; Drachman DB
Science; 1986 Apr; 232(4748):401-3. PubMed ID: 2938256
[TBL] [Abstract][Full Text] [Related]
7. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
Meinl E; Klinkert WE; Wekerle H
Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
[TBL] [Abstract][Full Text] [Related]
8. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
9. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
[TBL] [Abstract][Full Text] [Related]
10. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
[TBL] [Abstract][Full Text] [Related]
11. Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates.
Killen JA; Lindstrom JM
J Immunol; 1984 Nov; 133(5):2549-53. PubMed ID: 6332854
[TBL] [Abstract][Full Text] [Related]
12. Specific immunotherapeutic strategy for myasthenia gravis: targeted antigen-presenting cells.
Reim J; McIntosh K; Martin S; Drachman DB
J Neuroimmunol; 1992 Nov; 41(1):61-70. PubMed ID: 1460093
[TBL] [Abstract][Full Text] [Related]
13. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
Christadoss P; Lindstrom J; Talal N
Cell Immunol; 1983 Oct; 81(1):1-8. PubMed ID: 6577968
[TBL] [Abstract][Full Text] [Related]
14. An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides.
Pachner AR; Kantor FS; Mulac-Jericevic B; Atassi MZ
Immunol Lett; 1989 Feb; 20(3):199-204. PubMed ID: 2469649
[TBL] [Abstract][Full Text] [Related]
15. Induction of acetylcholine receptor-specific suppression. An in vitro model of antigen-specific immunosuppression in myasthenia gravis.
Bogen S; Mozes E; Fuchs S
J Exp Med; 1984 Jan; 159(1):292-304. PubMed ID: 6198424
[TBL] [Abstract][Full Text] [Related]
16. Prospects for specific immunotherapy in myasthenia gravis.
Steinman L; Mantegazza R
FASEB J; 1990 Jul; 4(10):2726-31. PubMed ID: 2197152
[TBL] [Abstract][Full Text] [Related]
17. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine receptor and thymus in experimental autoimmune myasthenia gravis and experimental myositis.
Ueno S; Wada K; Kang J; Takahashi M; Tarui S
Clin Exp Immunol; 1982 Dec; 50(3):563-71. PubMed ID: 7165999
[TBL] [Abstract][Full Text] [Related]
19. T-cell vaccination in experimental myasthenia gravis: a double-edged sword.
Kahn CR; McIntosh KR; Drachman DB
J Autoimmun; 1990 Dec; 3(6):659-69. PubMed ID: 2150910
[TBL] [Abstract][Full Text] [Related]
20. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
